Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Marschalek

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal TransitionAhmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Haematologica|December 14, 2004
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasmsThorben Kracht, Martin Schrappe, Sabine Strehl, et al.
Leukemia|April 26, 2023
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcomeMarius Külp, Patrizia Larghero, Julia Alten, et al.
Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemiaJennifer Richmond, Hernan Carol, Kathryn Evans, et al.
Haematologica|January 16, 2014
Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangementJohn Jeongseok Yang, Tae Sung Park, Seung-Tae Lee, et al.
Haematologica|October 27, 2012
Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemiasSang-Guk Lee, Sun Young Cho, Min Jin Kim, et al.
Blood Advances|March 17, 2022
The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemiaRahul Kumar, Raquel S Pereira, Julian Niemann, et al.
Blood|January 13, 2011
ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signalingLilian Kuster, Reinhard Grausenburger, Gerhard Fuka, et al.
Neoplasia (New York, N.Y.)|April 19, 2026
Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia modelPia Radszuweit, Rahel Fitzel, Sarah Bruestl, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal TransitionAhmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Haematologica|December 14, 2004
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasmsThorben Kracht, Martin Schrappe, Sabine Strehl, et al.
Leukemia|April 26, 2023
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcomeMarius Külp, Patrizia Larghero, Julia Alten, et al.
Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemiaJennifer Richmond, Hernan Carol, Kathryn Evans, et al.
Haematologica|January 16, 2014
Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangementJohn Jeongseok Yang, Tae Sung Park, Seung-Tae Lee, et al.
Haematologica|October 27, 2012
Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemiasSang-Guk Lee, Sun Young Cho, Min Jin Kim, et al.
Blood Advances|March 17, 2022
The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemiaRahul Kumar, Raquel S Pereira, Julian Niemann, et al.
Blood|January 13, 2011
ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signalingLilian Kuster, Reinhard Grausenburger, Gerhard Fuka, et al.
Neoplasia (New York, N.Y.)|April 19, 2026
Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia modelPia Radszuweit, Rahel Fitzel, Sarah Bruestl, et al.
Pageof 19